Market cap of Allarity Therapeutics Inc. [ALLR] reaches 1.09M – now what?

Allarity Therapeutics Inc. [NASDAQ: ALLR] price surged by 32.11 percent to reach at $0.35. The company report on April 11, 2023 that Abstract Evaluating Allarity’s DRP® Companion Diagnostic for Cisplatin Accepted at 2023 ASCO Annual Meeting.


Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Abstract Evaluating Allarity’s DRP® Companion Diagnostic for Cisplatin Accepted at 2023 ASCO Annual Meeting.

A sum of 19582733 shares traded at recent session while its average daily volume was at 208.73K shares. Allarity Therapeutics Inc. shares reached a high of $3.86 and dropped to a low of $1.04 until finishing in the latest session at $1.44.

The average equity rating for ALLR stock is currently 3.00, trading closer to a bullish pattern in the stock market.

ALLR Stock Performance Analysis:

Allarity Therapeutics Inc. [ALLR] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 16.13. With this latest performance, ALLR shares dropped by -68.35% in over the last four-week period, additionally sinking by -95.33% over the last 6 months – not to mention a drop of -97.80% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALLR stock in for the last two-week period is set at 29.17, with the RSI for the last a single of trading hit 31.92, and the three-weeks RSI is set at 30.03 for Allarity Therapeutics Inc. [ALLR]. The present Moving Average for the last 50 days of trading for this stock 4.7957, while it was recorded at 1.2430 for the last single week of trading, and 22.1774 for the last 200 days.

Insight into Allarity Therapeutics Inc. Fundamentals:

Return on Total Capital for ALLR is now -132.51, given the latest momentum, and Return on Invested Capital for the company is -141.20. Return on Equity for this stock declined to -155.34, with Return on Assets sitting at -50.04. When it comes to the capital structure of this company, Allarity Therapeutics Inc. [ALLR] has a Total Debt to Total Equity ratio set at 197.62. Additionally, ALLR Total Debt to Total Capital is recorded at 66.40, with Total Debt to Total Assets ending up at 25.68.

Reflecting on the efficiency of the workforce at the company, Allarity Therapeutics Inc. [ALLR] managed to generate an average of -$1,784,222 per employee.Allarity Therapeutics Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.40 and a Current Ratio set at 0.40.

Allarity Therapeutics Inc. [ALLR] Insider Position Details

There are presently around $0 million, or 1.70% of ALLR stock, in the hands of institutional investors. The top three institutional holders of ALLR stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 1,108, which is approximately 53.463% of the company’s market cap and around 4.55% of the total institutional ownership; GEODE CAPITAL MANAGEMENT, LLC, holding 841 shares of the stock with an approximate value of $1000.0 in ALLR stocks shares; and MORGAN STANLEY, currently with $1000.0 in ALLR stock with ownership of nearly 20400% of the company’s market capitalization.

Positions in Allarity Therapeutics Inc. stocks held by institutional investors increased at the end of Friday and at the time of the Friday reporting period, where 4 institutional holders increased their position in Allarity Therapeutics Inc. [NASDAQ:ALLR] by around 1,615 shares. Additionally, 4 investors decreased positions by around 2,191 shares, while 4 investors held positions by with 340 shares. The mentioned changes placed institutional holdings at 4,146 shares, according to the latest SEC report filing. ALLR stock had 2 new institutional investments in for a total of 413 shares, while 2 institutional investors sold positions of 1,776 shares during the same period.


Please enter your comment!
Please enter your name here